PYPDbenzinga

PolyPid Will Host A Conference Call And Webcast To Report Topline Data For The SHIELD II Phase 3 Trial, Evaluating D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery, On Monday, June 9, At 8:30 a.m

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on June 6, 2025 by benzinga

    PolyPid Will Host A Conference Call And Webcast To Report Topline Data For The SHIELD II Phase 3 Trial, Evaluating D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery, On Monday, June 9, At 8:30 a.m | PYPD Stock News | Candlesense